Commentary: Shining a light on shorts will improve market integrity, investor protection | RVX.TO Message Board Posts

Resverlogix Corp.

  RVX.TO website

  • Important Upgrade Notice: 

    At 9 pm Central, Sunday 2/16/2020, we launched the following tools as Phase One of our Premium Plus service (full service package still under development): 

    1) Customizable Scrolling Ticker
    2) Portfolio Manager
    3) Stock-specific News & Trading Email Alert Notifications

    These products are immediately available to Precious Metal & Gemstone Patrons. 

    To watch a tutorial on the "regular" site, click here. On "premium," click here

RVX.TO   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  27048 of 27104  at  6/6/2019 4:59:24 PM  by


Commentary: Shining a light on shorts will improve market integrity, investor protection

More and more biotech companies are going public earlier in their growth phase, allowing everyday Americans to benefit from opportunities to invest in a diverse range of potentially high-growth companies. The initial public offering market in 2018 was among the strongest of the past decade. Specifically in the biotech and pharma sectors, we experienced a robust IPO pipeline, with 66 companies going public on Nasdaq, raising a total of $7.3 billion. Yet, young biotech companies quickly discover that the odds are stacked against them — with certain short sellers aiming to drive down their stock prices by disseminating spurious information and analysis about a company's prospects ... all while hiding in the dark.

When used appropriately, short selling can support America's capital markets by facilitating price discovery, enhancing market liquidity and promoting market efficiency. However, the lack of transparency in short-selling positions forces the market to speculate on the extent and motives of short activities and limits companies' abilities to engage with investors. It may also give rise to possibly abusive trading behavior that could make investors wary about providing the capital necessary to fund research and development

Even worse, when unscrupulous short sellers make false claims about biotech firms in order to profit financially, they divert investment from potentially life-saving research and development and unfairly harm the investors who make that research possible. The fact that these

The late Supreme Court Justice Louis Brandeis once said, "Sunlight is said to be the best of disinfectants," and we agree. Better disclosure of short-selling positions would enable investors to thoughtfully consider the claims being made by individuals who have profit at stake in influencing their behavior. It would allow issuers the opportunity to better engage their shareholder base and address both legitimate and unfounded investor concerns. And it would equip regulators with the tools necessary to identify potentially abusive trading behaviors, address misleading claims disseminated through new media and better enforce market abuse rules.

Congress should enact sensible transparency requirements for short positions to address current gaps in the disclosure framework, root out market abuse and restore confidence in the integrity of our public markets.

Jim Greenwood is the president and CEO of the Biotechnology Innovation Organization and Nelson Griggs is the president of the Nasdaq Stock Exchange. This content represents the views of the authors. It was submitted and edited under Pensions & Investments guidelines, but is not a product of P&I's editorial team.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 363
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by